AI-powered Kardi Ai ECG monitoring technology launched in India
Hyderabad, Sept 27 (TNT): Czech HealthTech company ‘ Kardi Ai’ has launched its artificial intelligence-powered long-term electrocardiogram (ECG) monitoring technology in India, offering an extended monitoring option to help detect intermittent cardiac rhythm abnormalities that may go unnoticed during conventional short-duration tests.
The ‘ Kardi Ai’ device was launched at a function held here on Saturday by Dr Balakrishna, Joint Director, Ministry of Electronics and Information Technology, in the presence of Kardi Ai Co-founder and CEO Ing. Vlastimil Hrabal, Director of International Operations and India Representative Dr Ramana Jagarlamudi, Eurasia Medical Technologies LLP Scientific Adviser and Co-founder Dr Raghavendra Rao, and CzechTrade India Director Ing. Josef Hrubec, among others.
Addressing on the occasion, Hrabal said the technology uses a wearable ECG chest strap, mobile connectivity and AI-supported analysis to enable long-term monitoring of heart rhythms during patients’ routine activities.
He said cardiac rhythm abnormalities may not occur during a brief ECG examination or a conventional 24-hour Holter recording.
Extended monitoring could provide physicians with a longer observation window to identify intermittent arrhythmias, he added.
According to the company, its technology has reported detection rates of up to 40 per cent, compared with around 2–5 per cent for conventional Holter monitoring.
The company noted that detection rates may vary depending on the monitoring protocol, patient population and clinical criteria.
The device is intended to support physicians and does not replace clinical diagnosis or medical decision-making.
Its AI-supported analysis is preliminary, with definitive diagnosis to be made by a physician following clinical evaluation.
The company said the device had obtained an MD-15 licence from the Government of India for import and sale in the country.
It is also CE-marked under the European Union medical-device regulatory framework and classified as a Class IIa medical device under EU MDR.
Hrubec said more than 37 Czech companies operate in India, with investments exceeding USD 283 million.
He said Kardi Ai reflected the growing presence of Czech innovation in areas such as healthcare technology, artificial intelligence and digital healthcare.
The India launch is being facilitated by Hyderabad-based Eurasia Medical Technologies LLP, the company’s authorised representative in India.
Jagarlamudi and Rao said the technology was being introduced amid growing interest in remote monitoring and AI-assisted clinical support.
They also said the company was exploring the possibility of setting up manufacturing facilities in India in the future.
The launch was attended by cardiologists, doctors, healthcare professionals and technology stakeholders, who discussed cardiac arrhythmias, long-term ECG monitoring and the role of AI-assisted ECG analysis in clinical practice.
TNT TS
